We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (376)
- Scheduling (national classification system) (174)
- Safety monitoring and information (31)
- COVID-19 (11)
- Manufacturing (11)
- Advertising (9)
- Clinical trials (6)
- Medicinal cannabis hub (6)
- Compliance and enforcement (5)
- Sunscreens (5)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Breast implant hub (1)
- Import and export (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
764 result(s) found, displaying 1 to 25
-
Meeting statementsThe Advisory Committee on Medical Devices (ACMD) held its 90th meeting on 16 April 2026.
-
Meeting statementsThe Advisory Committee on Medical Devices (ACMD) convened its 89th meeting on 19 February 2026.
-
Scheduling decisions (interim)Interim decisions and invitation for comment. Closing date: 10 July 2026.
-
Corporate reportsThis report summarises the outcomes of the Pharmacovigilance Inspection Program in the 2-year period. The deficiencies identified are presented along with case studies of critical deficiencies from this reporting period, to support medicine sponsors in the continual improvement of their pharmacovigilance systems.
-
Scheduling decisions (final)This web publication constitutes a notice for the purposes of regulation 42ZCZX of the Therapeutic Goods Regulations 1990 (the Regulations).
-
Scheduling decisions (interim)Interim decision on proposed amendment to the Poisons Standard closing 3 July 2026
-
Corporate reportsThis report provides information about the TGA’s regulatory performance for the 2024-25 financial year.
-
Meeting statementsCommunique from the 12th meeting of the Women's Health Products Working Group, 31 March 2026.
-
Scheduling decisions (final)This web publication constitutes a notice for the purposes of regulation 42ZCZS and regulation 42ZCZX of the Therapeutic Goods Regulations 1990 (the Regulations).
-
Meeting statementsAdvisory Committee on Vaccines meeting statement 56
-
Meeting statementsThe 88th meeting of the Advisory Committee on Medical Devices (ACMD) was held on 11 December 2025.
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Corporate reportsFind out about the seasonal influenza vaccines available for the 2026 southern hemisphere season.
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 6 November 2025
-
Scheduling submissionsFind out about the public submissions on scheduling matters referred to the ACMS
-
Scheduling decisions (final)This web publication constitutes a notice for the purposes of regulation 42ZCZS of the Therapeutic Goods Regulations 1990 (the Regulations).
-
Meeting statementsAdvisory Committee on Vaccines meeting statement 55
-
Scheduling decisions (final)This web publication constitutes a notice for the purposes of regulation 42ZCZS and regulation of the 42ZCX Therapeutic Goods Regulations 1990 (the Regulations).
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Scheduling submissionsFind out about the public submissions on scheduling matters referred to the ACMS, ACCS & Joint ACMS-ACCS MARCH, 2024
-
Meeting statementsOverview of the meeting to discuss proposed changes to the Authorised Prescriber application process
-
Scheduling decisions (interim)Interim decisions and invitation for comment. Closing date: 12 January 2026.
-
Scheduling decisions (interim)Interim decisions and invitation for comment. Closing date: 23 January 2026.
-
Meeting statementsCommunique from the 4th meeting of the Human Research Ethics Committee and TGA Clinical Trials Discussion Forum, 1 December 2025
-
Meeting statementsCommunique from the 11th meeting of the Women's Health Products Working Group, 30 October 2025